Last reviewed · How we verify
Placebo to match mirabegron — Competitive Intelligence Brief
phase 3
Urology
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match mirabegron (Placebo to match mirabegron) — Astellas Pharma Europe B.V.. This is an inert placebo formulation designed to match the physical and sensory characteristics of mirabegron for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match mirabegron TARGET | Placebo to match mirabegron | Astellas Pharma Europe B.V. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match mirabegron CI watch — RSS
- Placebo to match mirabegron CI watch — Atom
- Placebo to match mirabegron CI watch — JSON
- Placebo to match mirabegron alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match mirabegron — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-mirabegron. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab